Pieter S. Siebenga
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A split-face comparative performance evaluation of injectable hyaluronic acid-based preparations HCC and CPM-HA20G in healthy females.
Journal: Journal of cosmetic dermatology
Published: January 04, 2022
A phase I, randomized, double-blind, placebo-controlled, single- and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Nav 1.8 inhibitor, in healthy adults.
Journal: Clinical and translational science
Published: July 28, 2021
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.
Journal: British journal of clinical pharmacology
Published: July 28, 2021
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults.
Journal: Pain medicine (Malden, Mass.)
Published: February 05, 2021
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial.
Journal: Journal of psychopharmacology (Oxford, England)
Published: April 07, 2020
Simultaneous tracking of psychophysical detection thresholds and evoked potentials to study nociceptive processing.
Journal: Behavior research methods
Published: January 23, 2020
Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
Journal: Journal of cosmetic dermatology
Published: August 22, 2019
Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Nav 1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects.
Journal: Clinical and translational science
Published: February 20, 2019
The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects.
Journal: European journal of pain (London, England)
Published: October 16, 2018
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs.
Journal: European journal of pain (London, England)
Published: August 29, 2018
Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans.
Journal: British journal of anaesthesia
Published: July 25, 2018
Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects.
Journal: European journal of pain (London, England)
Published: March 21, 2018
Last Updated: 09/26/2026